Tuberculosis Infection Testing Market: Global Industry Research Report 2020-2027 | Envisage Research

Tuberculosis Infection Testing Market - By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Chest x-ray and Others (Including Drug Susceptibility Testing, Adenosine Deaminase (ADA) etc.)), By End-Users (Hospital laboratories, Research laboratories, Clinics laboratories, Diagnostic center, Others (including, home health agencies etc.)), By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 183

Status: Published

Report Code: EMR100365

Tuberculosis (TB) is a serious infectious disease that mainly affects the Lungs of the person. It is caused by bacteria that spread through the air from person to person through tiny droplets released into the air via coughs and sneezes. Most People who get infected with the bacteria that cause tuberculosis don't have symptoms. Treatment isn't always required for those without symptoms. When symptoms do occur, they usually include a cough (sometimes blood-tinged), weight loss, night sweats and fever. Patients with active symptoms require a long course of treatment involving multiple antibiotics that helps to cure the disease.

TB has been considered a fatal disease and can take lives. Therefore, the governments have taken strong action plans to control and prevent TB. It is known that before the condition gets worse and the person starts showing the active symptoms of TB it can be cured. It can partially be prevented by a vaccine. As it spreads easily, medical diagnosis from a medical professional is very important along with the lab tests to detect and diagnose the infection before developing into an active TB. It is a medium-term cure for the infection as it takes months of regular medication to cure the disease.

There is also a distinction between TB. It is divided into two types, named as Latent Tb and Active TB. In the condition of Latent TB, a person may have a TB infection, but the bacteria remain in the body in an inactive state and cause no symptoms. IT is also called as inactive TB. It can turn into an Active TB, so it is important to provide treatment for the person with latent TB and to help control the spread of TB. For Active TB it affects your Lungs and makes you sick and can even kill you.

There is another problem with the use of drugs in curing TB. Anti-TB medicines are used all over the world to cure the TB bacteria, but it has been often observed that some TB strains become resistant to the drugs and these drugs are unable to cure the disease. Drug resistance emerges when anti-TB medicines are used inappropriately, through incorrect prescription by health care providers, poor quality drugs, and patients stopping treatment prematurely. Due to which this second stage treatment of TB is more dangerous and have very less chances for the patients to recover. Hence it makes it more important to detect the bacteria and cure it before it becomes active in the body.

Analyst Commentary:

As Tuberculosis (TB) is a very serious Infectious disease and needs to be taken care properly and seriously otherwise it can lead to the loss of life, thus the countries have taken it very seriously and all the countries aim to make them TB free by the end of 2030 according to the report by the WHO. As it can be cured easily with proper medication, therefore the important task is to test and detect it in a person’s body, hence medical advancement has come up with many methods to test the TB infection.
There are two types of most basic test that are used to test the TB infection-TB Skin test and TB blood test. Factors in selecting which test to use include the reason for testing, test availability, and cost. Generally, it is not recommended to test a person with both a TB skin test and a TB blood test. The TB skin test is also called the Mantoux tuberculin skin test (TST). TB blood tests are also called interferon-gamma release assays or IGRAs.

Selection of the most suitable tests for detection of TB infection should be based on the context for testing, test availability, and overall cost effectiveness of testing. Early screening and targeted testing for tuberculosis (TB) is a key strategy for controlling and preventing infection. And the biggest market driver of the lobal tuberculosis testing market is increasing global prevalence of tuberculosis infection. Growing focus on awareness programs by the governmental and NGO’s across the globe, availability of new improved tests for TB, are contributing to the global growth of this market. However, high cost of testing procedure and requirement of specialized equipment for testing may hinder growth of global tuberculosis testing market.

As the initiative is to make all the world TB free, and even the companies are coming up with more and more innovative and economical ways to test the infection and curing it. Therefore, these are the top Manufactures in Global Tuberculosis Infection Testing Market: Danaher, Genedrive plc, Becton Dickinson, Qiagen, Thermo Fisher Scientific, Bio-Rad, Hologic, Roche, Hain Lifescience, Oxford Immunotec, Akonni Biosystems and Creative Diagnostics. As there are grown initiatives and more focus on curing this infection, this leads to the driving of the global tuberculosis infection testing market.

Segmentation by test type:
• Tuberculin Skin Test (TST)
• Interferon Gamma Released Assay (IGRA)
• Chest x-ray
• Others (including, drug susceptibility testing, adenosine deaminase (ADA) etc.)

Segmentation by End-Users:
• Hospital laboratories
• Research laboratories
• Clinics laboratories
• Diagnostic center
• Others (including, home health agencies etc.)

Segmentation by region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Segmentation:

Segmenting on the basis of test type can be done into four basic parts- Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Chest x-ray, Others (including, drug susceptibility testing, adenosine deaminase (ADA) etc.) On the basis of more and more customer preference of the tests Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA) are highly used by the customers as they are easy and more economical to the patients. Also, they are the most basic tests that are prescribed by the doctors to find the tuberculosis infection in a person. However, they are not successful in finding the latent TB due to which chest X-ray and other tests are also prescribed by the doctors.

Chest X-ray and other tests (including, drug susceptibility testing, adenosine deaminase (ADA) etc.) are more expensive and are only prescribed by some doctors only to detect the latent TB, or at the end of the TB cure course to check the complete removal of TB infection from the Lungs of the patient, as any strain of Tb infection left in the body can become latent TB and later become active TB, Also this leads to the growth of drugs resistance in the TB cells, which is more dangerous and more difficult cure, therefore it is important to cure the TB once at a time.

Tuberculosis infection testing market can also be segmented on the basis of End-Users into different types- Hospital laboratories, Research laboratories, Clinics laboratories, Diagnostic center, others (including, home health agencies etc.). On the basis of the End-user preference hospital laboratories are mostly used by the customers. Most people go to the hospitals and gets prescriptions from the doctors, and they suggest them their own hospital laboratories to get themselves tested. Research laboratories and clinics laboratories are the ones that follows after the hospital laboratories in preference by the End-Users.

Regional:

On the basis of geography, the global tuberculosis infection testing market can be divided into five types that are- North America, Europe, Asia Pacific, Latin America and Middle East & Africa. On the basis of regions by geography the region that is leading the global tuberculosis infection testing market is the Asia-Pacific market. Due to the very large population in the Asia-Pacific region it is the biggest global tuberculosis infection testing market. As Asia-Pacific region has China and India which are the biggest contributors in the terms of population as well as the tuberculosis infection testing market. The largest number of new TB cases occurs in Asia-Pacific region, followed by Middle East & Africa. The market in Middle East & Africa is expected to be emerging market of the global tuberculosis infection testing market owing to increasing prevalence of tuberculosis.

The less medical facilities in the Middle East & Africa region are the main cause of the increase in the cases of tuberculosis in the Middle East & Africa. This has led to the increase in the global tuberculosis testing market and also ensured that Middle East & Africa will follow Asia-Pacific. This is later followed by Latin-America then Europe and then North-America, due to technology advances these countries are able to control the TB infection hence they are behind the Asia-Pacific market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Tuberculosis Infection Testing Market
Chapter 5. Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
5.1. Global Tuberculosis Infection Testing Market Share, By Test Type, 2015 - 2027 (USD Million)
5.1.1. Tuberculin Skin Test (TST)
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Interferon Gamma Released Assay (IGRA)
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Chest x-ray
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Others (including, home health agencies etc.) (including, drug susceptibility testing, adenosine deaminase (ADA) etc.)
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
6.1. Global Tuberculosis Infection Testing Share, By End User, 2015 - 2027 (USD Million)
6.1.1. Hospital laboratories
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Research laboratories
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Clinics laboratories
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Diagnostic Center
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. Others (including, home health agencies etc.)
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Tuberculosis Infection Testing Market Overview, By Geography, 2015 – 2027 (USD Million)
7.1. Global Tuberculosis Infection Testing Market Share, By Geography, 2015 - 2027 (USD Million)
7.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 8. North America Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1. North America Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
8.1.3. North America Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
8.1.4. North America Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
8.1.4.2. Canada Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 9. Europe Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. Europe Global Tuberculosis Infection Testing Market Overview, 2015 – 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.3. Europe Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4. Europe Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.1.3. Germany Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.2.3. France Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.3.3. UK Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.4.3. Italy Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.5.3. Spain Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
9.1.4.6.3. Rest of Europe Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 10. Asia Pacific Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.4.1.3. India Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.2.2. China Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.4.2.3. China Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.4.3.3. Japan Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.4.2. South Korea Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.4.4.3. South Korea Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
10.1.4.5.3. Rest of Asia Pacific Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 12. South America Global Tuberculosis Infection Testing Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Global Tuberculosis Infection Testing Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
12.1.3. South America Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4. South America Global Tuberculosis Infection Testing Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.4.1. Brazil
12.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.1.2. Brazil Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
12.1.4.1.3. Brazil Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4.2. Argentina
12.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.2.2. Argentina Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
12.1.4.2.3. Argentina Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
12.1.4.3. Rest of South America
12.1.4.3.1. Market size and projections, 2015 – 2026
12.1.4.3.2. Rest of South America Global Tuberculosis Infection Testing Market Overview, By Test Type, 2015 - 2027 (USD Million)
12.1.4.3.3. Rest of South America Tuberculosis Infection Testing Market Overview, By End User, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Test Type development
Chapter 14. Key End User Analysis
14.1. Danaher
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Test Type Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Genedrive plc
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Test Type Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Becton Dickinson
14.4. Qiagen
14.5. Thermo Fisher Scientific
14.6. Bio-Rad
14.7. Hologic
14.8. Roche
14.9. Hain Life science
14.10. Oxford Immunotec
Chapter 15. Global Tuberculosis Infection Testing Market Cost Analysis
15.1. Global Tuberculosis Infection Testing Market Key Raw Materials Analysis
15.1.1. Key Raw Materials
15.1.2. Price Trend of Key Raw Materials
15.1.3. Key Suppliers of Raw Materials
15.1.4. Market Concentration Rate of Raw Materials
15.2. Proportion of Wing Cost Structure
15.2.1. Raw Materials
15.2.2. Labor Cost
15.2.3. Wing Expenses
15.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 16. Chain, Sourcing Strategy and Downstream Buyers
16.1. Global Tuberculosis Infection Testing Market Chain Analysis
16.2. Upstream Raw Materials Sourcing
16.3. Raw Materials Sources of Global Tuberculosis Infection Testing Market Major Manufacturers in 2019
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Electrical Damage
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Test Type Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Test Type Progress in Related Industry
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Tuberculosis Infection Testing Market share, by Test Type, 2020 & 2027 (%)
10. Global Tuberculosis Infection Testing Market share, by Test Type 2020 & 2027 (USD Million)
11. Global Tuberculosis Infection Testing Market share, by Tuberculin Skin Test (TST), by Test Type, 2020 & 2027 (USD Million)
12. Global Tuberculosis Infection Testing Market share, by Interferon Gamma Released Assay (IGRA), by Test Type, 2020 & 2027 (USD Million)
13. Global Tuberculosis Infection Testing Market share, by Chest x-ray, by Test Type, 2020 & 2027 (USD Million)
14. Global Tuberculosis Infection Testing Market share, by Other, by Test Type, 2020 & 2027 (USD Million)
15. Global Tuberculosis Infection Testing Market share, by End User, 2020 & 2027 (%)
16. Global Tuberculosis Infection Testing Market share, by Hospital Laboratories, by End User, 2020 & 2027 (USD Million)
17. Global Tuberculosis Infection Testing Market share, by Research Laboratories, by End User, 2020 & 2027 (USD Million)
18. Global Tuberculosis Infection Testing Market share, by Clinics Laboratories, by End User, 2020 & 2027 (USD Million)
19. Global Tuberculosis Infection Testing Market share, by Diagnostic Center, by End User, 2020 & 2027 (USD Million)
20. Global Tuberculosis Infection Testing Market share, by Other, by End User, 2020 & 2027 (USD Million)
21. Global Tuberculosis Infection Testing Market share, by region, 2020 - 2027(%)
22. Global Tuberculosis Infection Testing Market share, by region, 2019 - 2027(USD Million)
23. North America Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
24. North America Global Tuberculosis Infection Testing Market share, by Countries, 2020 & 2027 (%)
25. U.S. Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
26. Canada Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
27. Europe Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
28. Europe Global Tuberculosis Infection Testing Market share, by Countries, 2020 & 2027 (%)
29. Spain Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
30. UK Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
31. Italy Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
32. Germany Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
33. France Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
34. Rest of Europe Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
35. Asia-Pacific Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
36. Asia-Pacific Global Tuberculosis Infection Testing Market share, by Countries, 2020 & 2027 (%)
37. China Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
38. India Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
39. Australia Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
40. Japan Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
41. Rest of Asia-Pacific Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
42. Middle East & Africa Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
43. Middle East & Africa Global Tuberculosis Infection Testing Market share, by Countries, 2020 & 2027 (%)
44. GCC Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
45. South Africa Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
46. Rest of Middle East & Africa Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
47. South America Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
48. Brazil Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
49. Mexico Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
50. Argentina Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)
51. Rest Of South America Global Tuberculosis Infection Testing Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Tuberculosis Infection Testing Market, 2020-2027 (USD Million)
4. Tuberculosis Infection Testing requirement, by country, 2020-2027, (USD Million)
5. North America Global Tuberculosis Infection Testing Market, by Test Type, 2020-2027 (USD Million)
6. North America Global Tuberculosis Infection Testing Market, by End User, 2020-2027 (USD Million)
7. Europe Global Tuberculosis Infection Testing Market, by Test Type, 2020-2027 (USD Million)
8. Europe Global Tuberculosis Infection Testing Market, by End User, 2020-2027 (USD Million)
9. Asia Pacific Global Tuberculosis Infection Testing Market, by Test Type, 2020-2027 (USD Million)
10. Asia Pacific Global Tuberculosis Infection Testing Market, by End User, 2020-2027 (USD Million)
11. Middle East & Africa Global Tuberculosis Infection Testing Market, by Test Type, 2020-2027 (USD Million)
12. Middle East & Africa Global Tuberculosis Infection Testing Market, by End User, 2020-2027 (USD Million)
13. South America Global Tuberculosis Infection Testing Market, by Test Type, 2020-2027 (USD Million)
14. South America Global Tuberculosis Infection Testing Market, by End User, 2020-2027 (USD Million)
15. Global Tuberculosis Infection Testing Market, Company Market Share, 2018 (%)
16. SUN PHARMACEUTICAL INDUSTRIES LTD : Product Benchmarking
17. SUN PHARMACEUTICAL INDUSTRIES LTD : Financial Performance
18. Genedrive plc: Product Benchmarking
19. Genedrive plc: Financial Performance
20. Becton Dickinson: Product Benchmarking
21. Becton Dickinson: Financial Performance
22. Qiagen: Product Benchmarking
23. Qiagen: Financial Performance
24. Thermo Fisher Scientific: Product Benchmarking
25. Thermo Fisher Scientific: Financial Performance
26. Bio-Rad: Product Benchmarking
27. Bio-Rad: Financial Performance
28. Hologic: Product Benchmarking
29. Hologic: Financial Performance
30. Teva Pharmaceuticals Inc: Product Benchmarking
31. Teva Pharmaceuticals Inc: Financial Performance

The Leading Key Players in Tuberculosis Infection Testing Market

Danaher
Genedrive plc
Becton Dickinson
Qiagen
Thermo Fisher Scientific
Bio-Rad
Hologic
Roche
Hain Lifescience
Oxford Immunotec
Akonni Biosystems and Creative Diagnostics